Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Administered By

Awarded By

Contributors

Start/End

  • May 23, 2022 - March 31, 2025